TLC Seeks A Second Opinion On Doxolipad

 
• By David Wallace
  
EMA
The EMA’s CHMP Has Been Asked To Look Again At TLC’s Doxorubicin Hybrid • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation